Open original FDA record ↗Recall record
- FDA identifier
- Z-2786-2016
- Company in FDA record
- Howmedica Osteonics Corp.
- FDA record creation date
- Sep 12, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Since Stryker acquired the AccuLIF product in March of 2014, there have been Product Inquires (PIs) related to the PL implant confirming to have a reduction of height > 1 mm. The current occurrence rate for reported post-operative reduction of cage height (> 1mm) of AccuLIF PL Expandable Cages is approximately 0.47% and has demonstrated a slight upward trend since September 2015.
Source facts
- Action
- Stryker Spine sent an "Urgent Recall Letter and Product Accountability Form" dated July 26, 2016 to all affected customers. For patients who have had an AccuLIF Posterior Lumbar (PL) Expandable Interbody implant, Stryker Spine is recommending routine clinical and radiographic post-operated evaluation. Should the patient report any change in or develop near-onset symptoms, more urgent clinical and radiographic evaluation should be completed. Customers with questions should call 201-749-8389 or 201-749-8346.
- Initiated
- 2016-07-26
- Root cause
- Unknown/Undetermined by firm
- Terminated
- 2018-03-12
- Distribution
- NationwideDistribution
- Recall number
- Z-2786-2016
- Recall status
- Terminated
- CDRH record ID
- 148845
- FDA record created
- 2016-09-12
- Recall event number
- 74931